Cloning of hexamethylene-bis-acetamide-inducible transcript, HEXIM1, in human vascular smooth muscle cells

38Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The dedifferentiation and the abnormal growth of vascular smooth muscle cells (VSMC) is a major component of vascular diseases. Hexamethylene-bis-acetamide (HMBA) has recently been shown to modulate the differentiation and growth of VSMC in vitro and in vivo. To determine the mechanism of this effect, we treated human coronary artery VSMC with HMBA and analyzed the effect of HMBA on gene expression by mRNA differential display. HMBA modulated the expression of a number of specific message fragments. By Marathon extension and cDNA screening, we isolated a novel gene, HEXIM1, that is up-regulated in HMBA-stimulated VSMC. HEXIM1 cDNA has a length of 3624 bp and encodes for a protein of 359 amino acids. Northern blot analysis demonstrated that the level of HEXIM1 mRNA rapidly increased at 1 h after HMBA stimulation and was sustained for 48 h. These results suggest that HEXIM1 plays an important role in the regulation of the growth and differentiation of VSMC.

Cite

CITATION STYLE

APA

Kusuhara, M., Nagasaki, K., Kimura, K., Maass, N., Manabe, T., Ishikawa, S., … Yamaguchi, K. (1999). Cloning of hexamethylene-bis-acetamide-inducible transcript, HEXIM1, in human vascular smooth muscle cells. Biomedical Research, 20(5), 273–279. https://doi.org/10.2220/biomedres.20.273

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free